Vai alla homepage
4.6/5
TrustPilot

I migliori medici di Terapia mirata per il cancro ai polmoni in Turchia — TOP-10 medici

Confronta i migliori medici di Terapia mirata per il cancro ai polmoni e i prezzi in Turchia. Trova qui la tua scelta ideale.

Richiedi preventivi da 3 migliori specialisti di Terapia mirata per il cancro ai polmoni in Turchia

Selezioneremo i migliori medici in base alle tue esigenze e al tuo budget.

Medici top

10

Turchia

Recensioni

14000+

Da pazienti reali

Scegli il paese con i migliori prezzi per i servizi medici

Confronta i prezzi di Terapia mirata per il cancro ai polmoni nei principali paesi

Tocca un paese per vedere i migliori medici e i prezzi

South Korea
Spain
Germany
Turkey
$3,100 - $3,600
$3,400 - $11,500
$4,000 - $4,100
$5,000 - $5,700
$0
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000

Ricevi piani di trattamento personalizzati gratuiti e scegli l'opzione migliore. Nessun impegno · Nessun costo per i nostri servizi

Mostra prima:

32 persone hanno richiesto un preventivo lo scorso mese

Mustafa Solak

  • 5.0 Eccellente 1 recensioni
  • 20 anni di esperienza
  • Località: Turchia, Istanbul
  • Il dottor Solak è specializzato nel trattamento del tumore polmonare, avendo completato un programma di specializzazione presso l'Istituto dei Tumori dell'Università di Hacettepe, uno dei principali centri oncologici della Turchia.

    • Formazione presso il MD Anderson Cancer Center dell'Università del Texas
    • Esperienza con terapie mirate per vari tipi di tumori, incluso il cancro ai polmoni
    • Specializzato anche in tumori al seno, ovarici e gastrointestinali
    • Laureato presso l'Università di Hacettepe, la principale scuola di medicina della Turchia
  • Mostra di più
Prezzo del pacchetto da$5,000

55 persone hanno richiesto un preventivo lo scorso mese

Eda Tanrikulu

  • 5.0 Eccellente 2 recensioni
  • 21 anni di esperienza
  • Località: Turchia, Istanbul
  • Specializzato in oncologia medica e chemioterapia presso il Centro Medico Anadolu – eccelle nelle terapie mirate per il cancro ai polmoni.

    • Ha completato la formazione in oncologia medica presso l'Università di Marmara
    • Si è classificato terzo nell'esame di specialità in oncologia medica in Turchia
    • Ha guidato studi clinici internazionali in oncologia medica
    • Ex capo dell'oncologia medica presso l'Ospedale Haydarpaşa Numune
  • Mostra di più
Visita dal medico
Prezzo su richiesta

Tahsin Ozatli

  • 2016 anni di esperienza
  • Località: Turchia, Istanbul
  • Il medico è un oncologo specializzato nel trattamento dei tumori al seno, ai polmoni e gastrointestinali. Attualmente, il medico pratica presso l'Ospedale Universitario Istinye Liv.

    Con una carriera che si estende su molteplici istituzioni prestigiose, il medico ha servito come Specialista in Medicina Interna presso l'Ospedale Statale di Malatya, medico presso la Clinica Oncologica di Ankara e membro del Dipartimento di Oncologia presso l'Ospedale Regionale di Formazione e Ricerca di Erzurum.

    Il medico si è laureato presso la Facoltà di Medicina dell'Università di Selcuk e ha ottenuto il titolo di Professore Associato nel 2016.

  • Mostra di più
Visita dal medico
Prezzo su richiesta

Cemil Bilir

  • 21 anni di esperienza
  • Località: Turchia, Istanbul
  • Dr. Cemil Bilir is a professor of medical oncology at VM Medical Park Pendik Hospital in Istanbul. He specializes in immunotherapy and chemotherapy for lung, breast, and prostate cancers. A former research fellow at Northeastern University in Boston, he focused on pharmaceutical biotechnology and nanomedicine. Dr. Bilir works at a JCI-accredited facility where academic physicians provide around-the-clock care.

    • Member of the American Society of Clinical Oncology (ASCO) and ESMO.
    • Completed a specialized clinical rotation at the Cleveland Clinic in the U.S.
    • Treats complex oncological cases, including stage 4 lung cancer and sarcoma.
    • Current Ph.D. student in inorganic chemistry at Sakarya University.
  • Mostra di più
Visita dal medico
Prezzo su richiesta

Muhammed Mustafa Atci

  • 15 anni di esperienza
  • Località: Turchia, Istanbul
  • Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

    • Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
    • Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
    • Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
    • Treats complex oncological cases at the university-affiliated İstinye University clinic.
  • Mostra di più
Visita dal medico
Prezzo su richiesta

Ercan Ozden

  • 27 anni di esperienza
  • Località: Turchia, Istanbul
  • Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

    • Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
    • Treats patients at a JCI-accredited hospital in Istanbul.
    • Performs staging and biopsies for liver, lung, and pancreatic tumors.
    • Provides targeted immunotherapy using medications like Keytruda.
  • Mostra di più
Visita dal medico
Prezzo su richiesta

Mustafa Serkan Alemdar

  • 20 anni di esperienza
  • Località: Turchia, Adalia
  • Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

    • Treats a wide range of cancers including breast, lung, and prostate.
    • Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
    • Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
    • Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.
  • Mostra di più
Visita dal medico
Prezzo su richiesta

Nail Paksoy

  • 15 anni di esperienza
  • accreditamenti:
  • Località: Turchia, Istanbul
  • Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

    • Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
    • Authored over 40 research articles in journals indexed by SCI and SSCI.
    • Completed dual fellowships in allergy-immunology and medical oncology.
    • Treats complex sarcomas and renal cell carcinomas with systemic therapies.
  • Mostra di più
Visita dal medico
Prezzo su richiesta

Scegliere una clinica all'estero può essere stressante. Da Bookimed, con oltre 800.000 pazienti aiutati, comprendiamo le tue preoccupazioni. Sappiamo come trovare medici affidabili, le migliori opzioni per rapporto qualità-prezzo e soluzioni anche per casi complessi. Siamo qui per guidarti in ogni fase del tuo percorso sanitario.

Yan Matsiivskiy

Capo del team dei coordinatori medici

Oltre 4300+ viaggi assistiti di pazienti

3 anni su Bookimed

278 pazienti da Turkey hanno trovato il loro medico tramite noi questo mese

Come troverai il medico perfetto per te

1

Quiz da 2 minuti

Dicci il tuo obiettivo, budget e tempistiche

2

Abbinamento umano + IA

Il nostro algoritmo trova le corrispondenze, il coordinatore verifica l'idoneità

3

Le tue opzioni pronte

Confronta prezzi, pacchetti, date. Chatta con il tuo coordinatore

Tante opzioni e non sai cosa scegliere?

Il tuo personale Il coordinatore Bookimed ti aiuta a trovare il chirurgo perfetto per le tue esigenze

  • Ti supporta 24/7 in ogni fase
  • Ti aiuta a trovare il medico più adatto e gestisce tutte le comunicazioni con le cliniche
  • Coordina viaggio, alloggio e trasferimenti

Guida il tuo percorso di cura

Coordinatori personali medici qualificati

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

Come scegliere il medico e la clinica giusti: consigli degli esperti

Quando scegli un medico o una clinica, tieni presente questi punti chiave:
Controlla le credenziali
Verifica le certificazioni di enti come ISAPS, JCI o degli ordini medici pertinenti.
Verifica i tassi di successo
Scegli medici con grande esperienza e comprovata competenza nel trattamento specifico.
Leggi le recensioni dei pazienti
Recensioni reali dei pazienti Bookimed per conoscere la loro esperienza.
Assicura una comunicazione efficace
Scegli cliniche che offrono servizio di traduzione per facilitare il trattamento.
Chiedi informazioni sui servizi
Conferma se il prezzo include servizi come alloggio, trasferimenti locali e assistenza post-trattamento per evitare costi nascosti.

Bookimed Insights: Principali specialisti in Terapia mirata per il cancro ai polmoni in Turchia (2026)

Bookimed ha coordinato 54636 richieste per Terapia mirata per il cancro ai polmoni in Turchia, collaborando con 10 specialisti di alto livello. I medici in questa tabella sono selezionati in base alle loro credenziali internazionali, esperienza clinica e risultati dei pazienti. La classifica del 2026 è composta da dati verificati su casi reali e dai programmi attuali delle nostre cliniche partner.
ClassificaMedicoesperienzaBuona scelta perCosa li distingueClinica e posizioneConsulto
#120 anni di esperienzaTerapia mirata per il cancro al polmoneFormazione specialistica presso l'illustre Istituto Oncologico di Hacettepe con ulteriore formazione presso il MD Anderson. Si specializza in approcci di oncologia di precisione.
Turchia
da $100
#221 anni di esperienzaTerapia mirata per il cancro ai polmoniEccelle nelle terapie mirate e nella chemioterapia per il tumore polmonare. Riconosciuto a livello nazionale e coinvolto nella ricerca clinica.
Turchia
da $215

FAQ: Medici per Terapia mirata per il cancro ai polmoni in Turchia

Queste domande frequenti provengono da pazienti reali che cercano assistenza medica tramite Bookimed. Le risposte sono fornite da coordinatori medici esperti e rappresentanti affidabili delle cliniche.

Which leading oncologists in Turkey specialize in targeted therapy for lung cancer?

Leading oncologists in Turkey specializing in lung cancer targeted therapy include Dr. Mustafa Solak, Dr. Eda Tanrikulu, and Assoc. Prof. Nail Paksoy. These experts utilize molecular profiling to match patients with precision medications. Most hold international certifications and completed fellowships at prestigious cancer institutes globally.

  • Molecular specialization: Assoc. Prof. Nail Paksoy focuses on ALK-positive NSCLC and next-generation ALK inhibitors.
  • International training: Dr. Mustafa Solak completed specialized training at The University of Texas MD Anderson Cancer Center.
  • Academic expertise: Dr. Eda Tanrikulu is a former oncology head with extensive clinical trial experience.
  • Precision research: Prof. Cemil Bilir integrates pharmaceutical biotechnology research into advanced lung cancer treatment protocols.

Bookimed Expert Insight: Data shows that top Turkish oncologists like Dr. Eda Tanrikulu and Assoc. Prof. Nail Paksoy frequently participate in international clinical trials. This ensures patients access emerging therapies before they become widely available elsewhere. Choosing doctors at academic centers like Anadolu Medical Center or Istinye University Liv Hospital provides access to multidisciplinary tumor boards.

Patient Consensus: Patients emphasize the need for doctors who order molecular testing immediately to find specific mutations. They often mention that quick coordination between pathology and oncology is more vital than a doctor's fame. Many noted that successful treatment depended on the oncologist's willingness to perform a re-biopsy when the cancer changed.

How do Turkish lung cancer doctors determine if a patient is eligible for targeted therapy?

Turkish lung cancer doctors determine eligibility through comprehensive molecular profiling of tumor tissue or blood. Specialists identify specific genetic mutations like EGFR or ALK to match patients with precise treatments. This process avoids unnecessary chemotherapy by focusing only on drugs that target the tumor's unique DNA signature.

  • Molecular testing: Pathologists analyze biopsies for driver mutations such as ROS1, BRAF, and KRAS.
  • Next-generation sequencing: Centers like Acibadem use advanced sequencing to scan multiple genetic markers simultaneously.
  • Liquid biopsies: Doctors test blood samples for circulating tumor DNA if traditional biopsies are impossible.
  • Clinical assessment: Specialists verify if the patient can tolerate oral medications and matching drugs exist.

Bookimed Expert Insight: Turkish oncology stands out because leading specialists often combine domestic expertise with top-tier international training. For example, Dr. Mustafa Solak at Hisar Hospital practiced at MD Anderson, while Dr. Eda Tanrikulu at Anadolu trained at Oxford. This allows them to apply global precision medicine protocols using both RNA and DNA testing to ensure no gene fusions are missed.

Patient Consensus: Patients note that initial biopsies may not always include a full genetic panel unless specifically requested. They highlight the importance of obtaining the complete pathology report to confirm matching driver mutations. Many were surprised to learn that testing continues even after treatment begins to catch new mutations.

Do Turkish oncologists follow international protocols for targeted therapy management?

Turkish oncologists strictly adhere to international protocols for lung cancer management. Leading specialists utilize European Society for Medical Oncology (ESMO) and National Comprehensive Cancer Network (NCCN) frameworks. This ensures patients receive standardized precision care comparable to top institutions in the United States and Europe.

  • International certifications: Dr. Nail Paksoy holds ESMO Board Certification in Medical Oncology from Paris.
  • Global academic training: Dr. Mustafa Solak completed specialized training at the MD Anderson Cancer Center.
  • Precise molecular testing: Specialists at JCI-accredited hospitals use next-generation sequencing to identify specific tumor mutations.
  • Multidisciplinary review: Complex cases undergo evaluation by tumor boards to determine the best treatment sequence.

Bookimed Expert Insight: Data shows Turkish oncology attracts professors with extensive international research backgrounds. For instance, Prof. Cemil Bilir conducted pharmaceutical biotechnology research at Northeastern University in Boston. This academic integration means Turkish centers often provide access to advanced molecular insights before standard options are exhausted.

Patient Consensus: Patients emphasize the importance of having full molecular testing done before starting any drugs. Many felt more confident after seeing their cases reviewed by a team of different specialists. Direct explanations about which biomarkers were checked helped them understand the treatment plan better.

How do Turkish specialists coordinate treatment decisions for complex advanced lung cancer cases?

Turkish specialists coordinate complex lung cancer care through multidisciplinary tumor boards and integrated molecular diagnostics. These teams include medical oncologists, thoracic surgeons, and radiation experts who jointly review pathology. This collaborative framework ensures evidence-based decisions for advanced cases before systemic therapy begins.

  • Tumor board reviews: Weekly meetings unite various specialists to create a single synchronized treatment roadmap.
  • Genomic profiling: Experts like Dr. Eda Tanrıkulu evaluate EGFR, ALK, and ROS1 mutations.
  • Radiation coordination: Professors such as Berrin Pehlivan integrate stereotactic radiotherapy into systemic plans.
  • Global standards: JCI-accredited centers often maintain affiliations with prestigious institutions like Johns Hopkins Medicine.

Bookimed Expert Insight: Coordination in Turkey often centers on specialized molecular research hubs within hospitals. For instance, Dr. Muhammed Mustafa Atci and Professor Cemil Bilir combine academic research with clinical practice. This allows patients to access sequence-adjusted therapeutic models. These models may bypass traditional chemotherapy in favor of frontline targeted options based on real-time genomic data.

Patient Consensus: Patients note that getting molecular testing early is vital for successful targeted treatment decisions. They emphasize that the best results come from hospitals where specialists communicate directly. Many suggest bringing original biopsy blocks and digital scans to help teams verify previous findings quickly.

Can international patients communicate effectively with Turkish target therapy specialists?

International patients communicate effectively with Turkish lung cancer specialists through English-speaking doctors and dedicated care teams. Many oncologists hold European Society for Medical Oncology (ESMO) certifications. They often complete international fellowships. Private hospitals provide professional translators for and medical record coordination.

  • Specialist fluency: Top doctors often graduate from English-language medical programs or train at US-based centers.
  • Dedicated coordinators: Hospitals assign multilingual staff to assist with medical record translation and scheduling.
  • Global standards: Specialists follow international protocols from ESMO and ASCO, ensuring clear technical communication.
  • Academic expertise: Many professors publish research in English-language journals to maintain their prestigious board certifications.

Bookimed Expert Insight: Data shows that choosing doctors with international training, like Dr. Mustafa Solak who trained at MD Anderson or Dr. Cemil Bilir who conducted research at Northeastern University, often results in smoother communication. These specialists are accustomed to the precision required for discussing genetic biomarkers and complex targeted drug protocols with global patients.

Patient Consensus: Patients note that communication is most effective at major centers with established international departments. They often find that while the specialist speaks English, having a dedicated coordinator helps manage the smaller details of their treatment plan. Many emphasize the importance of having all biopsy and mutation reports translated before the first consultation.

How do Turkish doctors manage follow-up care for international targeted therapy patients?

Turkish oncologists manage follow-up through hybrid care models combining remote digital monitoring with scheduled clinical visits. They establish protocols for molecular testing and toxicity tracking. Local teams coordinate with home-country doctors to integrate reports and imaging results. Bookimed manages all logistics and scheduling for these transitions.

  • Molecular monitoring: Doctors schedule liquid biopsies or PET-CT scans to track tumor response and resistance.
  • Toxicity management: Specialists provide strict timelines for home-country blood tests to monitor liver and renal function.
  • Remote consultations: Patients access video appointments starting from $100 to review lab data and adjust dosages.
  • Documentation hand-off: International departments generate exhaustive English medical reports and mutation panels for local oncologists.

Bookimed Expert Insight: Leading oncology centers in Turkey often integrate research-level precision into follow-up care. For example, Dr. Eda Tanrikulu at Anadolu Medical Center has led international clinical studies, while Dr. Nail Paksoy at Medipol focuses specifically on next-generation ALK inhibitors. This expertise means follow-up plans are not just about checking stats, but anticipating exactly when a specific targeted agent might need switching based on published real-world outcomes.

Patient Consensus: Patients note the importance of securing a clear next steps document before leaving Istanbul. They emphasize that while WhatsApp and email help, having every imaging CD and English pathology report is vital for their home doctors. Most feel relieved when a concrete schedule for blood work and symptom triggers is clearly written out.